Filing Details
- Accession Number:
- 0001493152-23-004168
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-09 20:11:50
- Reporting Period:
- 2023-02-09
- Accepted Time:
- 2023-02-09 20:11:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1444307 | Oncosec Medical Inc | ONCS | Pharmaceutical Preparations (2834) | 980573252 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1728262 | J Robert Delaversano | C/O Oncosec Medical Incorporated 24 North Main Street Pennington NJ 08534 | Vp, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-09 | 40 | $1.37 | 1,008 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- In connection with the vesting of 49 RSUs on February 1, 2023, a total of 40 shares were sold in order to satisfy the reporting person's tax withholding obligations. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies.
- Effective as of 12:01 a.m. Eastern Time on November 9, 2022, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-22.
Billionaire Hedge Funds
